Anebulo Pharmaceuticals, Inc.
ANEB
$2.64
-$0.07-2.58%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/25/2025
-
MarketBeat
10/8/2025
-
MarketBeat
9/29/2025
-
Nasdaq News: Markets
9/29/2025
-
Zolmax
9/29/2025
-
GuruFocus
9/29/2025
-
MarketBeat
9/29/2025
-
Business Wire
9/25/2025
-
GuruFocus
9/25/2025
-
GuruFocus
9/25/2025
-
TipRanks Financial Blog
9/25/2025
-
The Fly
9/25/2025
-
Business Wire
9/17/2025
-
MarketBeat
9/12/2025
-
GuruFocus
9/12/2025
-
GuruFocus
9/12/2025
-
TipRanks Financial Blog
9/12/2025
-
The Fly
9/12/2025
-
Business Wire
9/9/2025
-
Simply Wall St
9/1/2025
-
MarketBeat
8/16/2025
-
MarketBeat
8/9/2025
-
MarketBeat
7/24/2025
-
MarketBeat
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, September 29, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
512 598 0931
Address
1017 Ranch Road 620 South
Lakeway, TX 78734
Lakeway, TX 78734
Country
Year Founded
Business Description
Sector
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute...
more